Share of Cost, New research leads to FDA approval of first drug to treat radiation sickness
Tuesday, Sep. 15th 2015 6:00 AM
New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.
Related posts:
- Share of Cost, Prostate Cancer And Radiation Therapies, The Need For Additional Treatments In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton therapy […]...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Share of Cost, Researchers find potential target for drug to treat allergic asthma Share of Cost, Researchers find potential target for drug to treat allergic asthma...
- Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA...
- Share of Cost, FDA Approves New Multiple Sclerosis Drug Share of Cost, FDA Approves New Multiple Sclerosis Drug...
- Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
- Share of Cost, Antacid cimetidine could be 1 of many common over-the-counter medicines to treat cancer Share of Cost, Antacid cimetidine could be 1 of many common over-the-counter medicines to treat cancer...
- Share of Cost, Stem Cells Harvested From Human Gut For First Time Share of Cost, Stem Cells Harvested From Human Gut For First Time...
- Youth Buffered Against Risk Factors Related To Drug Abuse By Healthy Family Relationships And Religious Involvement American-Indian adolescents continue to have the highest rates of illicit drug use among all ethnic groups. Although previous research has found that increasing adolescent exposure to protective factors can reduce their risk for substance abuse, this has not been thoroughly examined in American-Indian adolescents…...
- Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA: The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well […]...
- Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in […]...
- Xofigo an Advanced Prostate Cancer Drug Approved By FDA Xofigo an Advanced Prostate Cancer Drug Approved By FDA ...
- Share of Cost, Vitamin D May Help Treat Asthma Share of Cost, Vitamin D May Help Treat Asthma...
- Share of Cost, One In 3 Ventilated Patients Suffers From PTSD Symptoms Share of Cost, One In 3 Ventilated Patients Suffers From PTSD Symptoms...
- Share of Cost, Two Talks With Teens Leads To Less Marijuana Use For At Least A Year Marijuana is the most prevalent illicit drug used by teenagers and adults around the world. Nearly a third of high school students in the United States report smoking it, and most high schoolers say they have access to the drug. To many people, smoking pot is no big deal. They cite reasons such as: “it […]...
Posted on Tuesday, Sep. 15th 2015 6:00 AM | by Share of Cost | in Share of Cost | No Comments »